SHINE SA Media Release: Response to ABC report on Long Acting Reversible Contraception (LARCs)

SHINE SA, Issued: 13 December 2017

SHINE SA believes that decisions about contraception should be made in conjunction with a health care professional and that everyone should have access to accurate and unbiased information to enable appropriate informed contraceptive choice.

LARCs (Long Acting Reversible Contraception) including the levonorgestrel IUD1 (Mirena) and the subdermal implant (Implanon NXT) are the most effective reversible methods of contraception available. They have the additional advantage of being long lasting, convenient to use and generally well regarded by most users. LARC method failure rates rival that of tubal sterilization at <1% and unintended pregnancy rates are lower than those reported for contraceptive pill users.

Like all progestogen only contraceptive methods, LARCs may result in a change of bleeding pattern which may include no bleeding, frequent or prolonged bleeding. Users of the levonorgestrel IUD most commonly experience a reduction in bleeding over time and it is used as a treatment for Heavy Menstrual Bleeding for this reason. Only 1 in 5 users of the contraceptive implant have an increase in bleeding that persists beyond the first few months.

LARC use, and in particular the subdermal implant, is not known to be associated with pelvic inflammatory disease (PID) which is an infection of the upper part of the female reproductive system namely the uterus, fallopian tubes, and ovaries. PID is a known side effect of IUD insertion but occurs in less than 1 in 300 people. The risk of PID is only increased for the first 3 weeks after insertion, after which it returns to the previous background risk. Users of IUDs are encourage to return at any sign of infection and when treated promptly with antibiotics are unlikely to experience any long term complications.

Contraception for women living with violence

Children by Choice, Last modified on: 22 May 2017

Contraceptive use is often compromised for women living with violence. 

Contraceptive options that are safe and appropriate for one woman may not work for another. If you’re working with women experiencing violence, it’s important to explore each woman’s unique circumstances and draw on her own knowledge to assess the degree of comfort and safety with her contraceptive options.

Important factors to consider include whether the perpetrator is likely to:

  • Monitor the woman’s Medicare or prescription records through her MyGov account;
  • Restrict or monitor access to health care professionals;
  • Monitor menstruation and fertility patterns;
  • Engage in severe physical assaults;
  • Be actively searching for the use of contraceptive drugs or devices; and/or
  • Engage in rape and other forms of sexual assault.

This guide is not intended to replace a full medical consultation with a professional, but does provide a starting point for thinking further about which contraceptive options might be safest and most appropriate given an individual patient’s or client’s circumstances.

  • Read more here
  • Download full resource (PDF) here 

 

Mirena IUD effective for seven years: new study

Dr Jennifer Gunter, September 10 2016

The Mirena intrauterine system (IUS), the IUD with the hormone levonorgestrel, is a highly effective method of contraception currently approved for five years. Some data suggests that it probably good for six years, but a new study tells us with a good degree of confidence that the Mirena is safe and effective for seven years. 

The study was funded by UNDP/ UNFPA/WHO/World Bank Special Programme of Research and published in the journal Contraception.